Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma: Current State and Recent Advances

被引:2
作者
Yakob M. [1 ]
Fuentes L. [1 ]
Wang M.B. [2 ]
Abemayor E. [2 ]
Wong D.T.W. [1 ]
机构
[1] Center for Oral/Head & Neck Oncology Research, School of Dentistry, University of California, Los Angeles, 73-017 CHS, 10833 Le Conte Avenue, Los Angeles, 90095, CA
[2] Department of Head and Neck Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA
基金
美国国家卫生研究院;
关键词
Exosomes; Metabolomics; Methylomics; Microbiomics; Oral cancer; Oral fluid diagnostics; Oral squamous cell carcinoma; Proteomics; Salivaomics; Salivary biomarker; Salivary diagnostics; Transcriptomics;
D O I
10.1007/s40496-014-0014-y
中图分类号
学科分类号
摘要
Oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm of the oral cavity. Detection of OSCC is currently based on a thorough clinical oral examination combined with a biopsy for histological analysis. Most cases of OSCC are not detected until the cancer has developed into advanced stages; thus, a reliable early-stage diagnostic marker is needed. This literature review presents an overview of the status of current advances in salivary diagnostics for OSCC. Though many protein and mRNA salivary biomarkers have been identified that can detect OSCC with high sensitivity and specificity, the most discernable findings occur with the use of multiple markers. Studies that incorporate proteomic, transcriptomic, and potentially additional “omics”, including methylomics, need to be initiated to bring technology to clinical applications and allow the best use of saliva in diagnosing OSCC. © 2014, Springer International Publishing AG.
引用
收藏
页码:133 / 141
页数:8
相关论文
共 97 条
[41]  
Akhter M., Hossain S., Rahman Q.B., Molla M.R., A study on histological grading of oral squamous cell carcinoma and its co-relationship with regional metastasis, J Oral Maxillofac Pathol, 15, 2, pp. 168-176, (2011)
[42]  
Rusthoven K., Ballonoff A., Raben D., Chen C., Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma, Cancer, 112, 2, pp. 345-351, (2008)
[43]  
Anneroth G., Batsakis J., Luna M., Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas, Scand J Dent Res, 95, 3, pp. 229-249, (1987)
[44]  
Wong D.T., Salivaomics, J Am Dent Assoc, 143, pp. 19S-24S, (2012)
[45]  
Dowling P., Wormald R., Meleady P., Henry M., Curran A., Clynes M., Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis, J Proteomics, 71, 2, pp. 168-175, (2008)
[46]  
Arellano-Garcia M.E., Hu S., Wang J., Henson B., Zhou H., Chia D., Et al., Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva, Oral Dis, 14, 8, pp. 705-712, (2008)
[47]  
Denny P., Hagen F.K., Hardt M., Liao L.J., Yan W.H., Arellanno M., Et al., The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions, J Proteome Res, 7, 5, pp. 1994-2006, (2008)
[48]  
Loo J.A., Yan W., Ramachandran P., Wong D.T., Comparative human salivary and plasma proteomes, J Dent Res, 89, 10, pp. 1016-1023, (2010)
[49]  
Bonne N.J., Wong D.T.W., Salivary biomarker development using genomic, proteomic and metabolomic approaches, Genome Med, 4, (2012)
[50]  
Sorsa T., Tjaderhane L., Salo T., Matrix metalloproteinases (MMPs) in oral diseases, Oral Dis, 10, 6, pp. 311-318, (2004)